Investment Analysts’ Ratings Reiterations for November 3rd (AAPL, ACG, BMRN, CHKP, CHRY, CMPS, CNA, CRSP, EDV, EVER)

Investment Analysts’ ratings reiterations for Tuesday, November 3rd:

Apple (NASDAQ:AAPL) had its neutral rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $303.00 price target on the stock.

Apple (NASDAQ:AAPL) had its underweight rating reissued by analysts at KeyCorp. The firm currently has a $250.00 price target on the stock.

ACG Acquisition (LON:ACG) had its buy rating reaffirmed by analysts at Canaccord Genuity Group. The firm currently has a GBX 2,295 price target on the stock.

ACG Acquisition (LON:ACG) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 2,300 target price on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its neutral rating reaffirmed by analysts at HC Wainwright. The firm currently has a $60.00 price target on the stock.

Check Point Software Technologies (NASDAQ:CHKP) had its neutral rating reiterated by analysts at Cantor Fitzgerald. They currently have a $150.00 price target on the stock.

Chrysalis Investments (LON:CHRY) had its buy rating reaffirmed by analysts at Jefferies Financial Group.

Compass Pathways (NASDAQ:CMPS) had its buy rating reiterated by analysts at BTIG Research. They currently have a $25.00 price target on the stock.

Centrica (LON:CNA) had its buy rating reissued by analysts at Jefferies Financial Group. Jefferies Financial Group currently has a GBX 200 price target on the stock.

CRISPR Therapeutics (NASDAQ:CRSP) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $82.00 target price on the stock.

Endeavour Mining (LON:EDV) had its buy rating reissued by analysts at Jefferies Financial Group. Jefferies Financial Group currently has a GBX 5,700 target price on the stock.

EverQuote (NASDAQ:EVER) had its buy rating reaffirmed by analysts at B. Riley Financial. The firm currently has a $35.00 price target on the stock, up from their previous price target of $34.00.

Fabrinet (NYSE:FN) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $500.00 price target on the stock.

Franchise Brands (LON:FRAN) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 185 price target on the stock.

GSK (LON:GSK) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 2,200 price target on the stock.

HCA Healthcare (NYSE:HCA) had its buy rating reiterated by analysts at Truist Financial. They currently have a $510.00 price target on the stock, up from their previous price target of $495.00.

Hiscox (LON:HSX) had its underperform rating reiterated by analysts at Jefferies Financial Group. The firm currently has a GBX 1,148 price target on the stock.

Ibstock (LON:IBST) had its hold rating reiterated by analysts at Jefferies Financial Group. They currently have a GBX 90 price target on the stock.

IWG (LON:IWG) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 350 price target on the stock.

IWG (LON:IWG) had its buy rating reissued by analysts at Jefferies Financial Group. Jefferies Financial Group currently has a GBX 235 price target on the stock.

Jadestone Energy (LON:JSE) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 75 price target on the stock.

Lyell Immunopharma (NASDAQ:LYEL) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $44.00 target price on the stock.

monday.com (NASDAQ:MNDY) had its buy rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $130.00 target price on the stock.

ServiceNow (NYSE:NOW) had its buy rating reaffirmed by analysts at Argus. Argus currently has a $170.00 price target on the stock.

onsemi (NASDAQ:ON) had its hold rating reaffirmed by analysts at TD Cowen. The firm currently has a $75.00 price target on the stock.

onsemi (NASDAQ:ON) had its neutral rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $90.00 price target on the stock.

Palantir Technologies (NASDAQ:PLTR) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $260.00 price target on the stock.

Palantir Technologies (NASDAQ:PLTR) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $250.00 target price on the stock.

Supermarket Income REIT (LON:SUPR) had its buy rating reissued by analysts at Jefferies Financial Group. They currently have a GBX 90 price target on the stock.

TAT Technologies (NASDAQ:TATT) had its buy rating reiterated by analysts at B. Riley Financial. The firm currently has a $63.00 price target on the stock, up from their previous price target of $60.00.

Tenet Healthcare (NYSE:THC) had its buy rating reissued by analysts at Truist Financial. They currently have a $305.00 price target on the stock, up from their previous price target of $290.00.

Focusrite (LON:TUNE) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 355 target price on the stock.

Upwork (NASDAQ:UPWK) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $8.00 target price on the stock.

V2X (NYSE:VVX) had its hold rating reaffirmed by analysts at Truist Financial. Truist Financial currently has a $87.00 target price on the stock, up from their previous target price of $85.00.

Exzeo Group (NYSE:XZO) had its buy rating reaffirmed by analysts at Truist Financial. They currently have a $24.00 target price on the stock, down from their previous target price of $25.00.